Harmoney debuts on the ASX

Harmoney debuts on the ASX
Rebecca Howard
A new lockdown in South Australia will crimp demand for SkyCity Entertainment and weigh on other travel stocks while investors will also keep an eye on Harmoney’s debut and earnings from AFT Pharmaceuticals.Online personal lender Harmoney is joining the ASX with a prospectus that would value the company at A$353 million for its initial public offering, and a secondary listing on the NZX.Harmoney’s IPO price of A$3.50 per share values the company at more than rival MoneyMe's current market capitalisation of A$226 million after be...

More Markets

Thinking of investing? Skip 'most' of NZX
Opinion

Simon Robertson: Thinking of investing? Skip 'most' of NZX

If you want to grow your wealth, then buy the S&P 500. Period.

Fisher and Paykel Healthcare drives NZ stocks to weaker finish
Markets Market Close

Fisher and Paykel Healthcare drives NZ stocks to weaker finish

The S&P/NZX 50 Index closed down 31.63 points, or 0.23%, to 13,483.99.

Jamie Gray 05 Dec 2025
Fletcher Building extends bank covenant deal
Markets

Fletcher Building extends bank covenant deal

The company cannot pay a dividend until it meets its standard covenant levels.

Rebecca Howard 05 Dec 2025
The small standout performers on the NZX
Retail Small Cap Wrap

The small standout performers on the NZX

The small cap index has a blinder in 2025, some small cap awards, and more.